FILING ANALYSIS · MONDAY, NOVEMBER 16
VYCOR MEDICAL INC VYCO — 8-K: Results of Operations and Financial Condition
negative
Vycor Medical reported a 19% decrease in revenue for the three months ended September 30, 2026, and an 11% decrease in revenue for the nine months ended September 30, 2026, with operating profit also decreasing, indicating a negative impact on the stock price. The company's non-GAAP operating profit also decreased, and the revenue decrease was largely due to lower US sales, which could lead to inv
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →